Search results
Tower Research Capital LLC TRC Raises Stock Holdings in Johnson Controls International plc...
ETF DAILY NEWS· 15 hours agoTower Research Capital LLC TRC increased its position in shares of Johnson Controls International...
Intervention Improves Sleep in Hospitalized Patients
Medscape· 19 hours agoNew research confirms that sleep often suffers during a hospital stay, but a simple patient-focused intervention can help reduce sleep disruptions.
Intermittent fasting plus protein pacing may boost weight loss, gut health
MedicalNewsToday via AOL· 3 days agoA study comparing continuous calorie restriction with a uniquely tailored intermittent fasting...
High Confidence AD Drug Donanemab Will Get FDA Panel Nod
Medscape· 4 days agoThe Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug...
Carter’s, Inc. (NYSE:CRI) Given Average Recommendation of “Reduce” by Analysts
ETF DAILY NEWS· 3 days agoEvercore ISI raised their price objective on Carter’s from $70.00 to $80.00 and gave the company an...
Integral Ad Science Holding Corp. (NASDAQ:IAS) Stock Position Lifted by Corient Private Wealth LLC
ETF DAILY NEWS· 19 hours agoCorient Private Wealth LLC grew its position in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS – Free Report) by 61.3% during the fourth quarter, according to the ...
MONECO Advisors LLC Raises Stock Holdings in Microsoft Co. (NASDAQ:MSFT)
ETF DAILY NEWS· 5 days agoMONECO Advisors LLC raised its holdings in shares of Microsoft Co. (NASDAQ:MSFT – Free Report) by 38.3% during the fourth quarter, Holdings Channel reports. The fund owned ...
Study Examines Merkel Cell Carcinoma in Non-White Hispanics
Medscape· 4 days agoThe findings underscore "the importance of considering race/ethnicity in understanding the...
Madre Armelle De Sells 4,442 Shares of Datadog, Inc. (NASDAQ:DDOG) Stock
ETF DAILY NEWS· 2 days agoDatadog, Inc. (NASDAQ:DDOG – Get Free Report) insider Madre Armelle De sold 4,442 shares of Datadog stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average ...
Improved Outcomes With Subcutaneous Amivantamab in NSCLC
Medscape· 6 days agoSubcutaneous amivantamab plus lazertinib may offer a survival benefit over intravenous administration, alongside dramatically reduced administration times, a new study suggests.